Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (11 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Collaboration revenue
7
45
68
41
3
Research and development
23
38
58
76
111
General and administrative
5
8
14
21
24
Total operating expenses
28
46
72
96
135
Operating loss
-21
-1
-3
-55
-133
Interest income, net
0
0
0
0
0
Other income (expense), net
0
0
0
0
0
Other income (expense), net
0
0
0
0
0
Loss before income taxes
-21
-1
-3
-55
-132
Income tax expense
0
0
0
0
0
Net loss
-21
-1
-3
-55
-132
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (26 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
98
124
190
208
Accounts receivable
n/a
2
34
2
0
Prepaid expenses and other current assets
n/a
1
2
3
4
Total current assets
n/a
101
160
195
213
Property and equipment, net
n/a
2
2
4
4
Restricted cash and other assets
n/a
1
1
1
1
Total assets
n/a
104
163
199
218
Liabilities and owners' equity
Accounts payable
n/a
3 2967000
5 4698000
8 8300000
5 4653000
Accrued expenses
n/a
4 4328000
7 6632000
7 7043000
11 11335000
Current portion of capital lease obligation
n/a
0 0
0 0
0 0
1 561000
Current portion of deferred revenue
n/a
28 28208000
23 23243000
2 1702000
2 1900000
Total current liabilities
n/a
36 35503000
35 34573000
17 17045000
18 18449000
Capital lease obligation, net of current portion
n/a
0 0
0 0
0 0
1 730000
Deferred revenue, net of current portion
n/a
41 41237000
24 23629000
21 21449000
29 28809000
Other long-term liabilities
n/a
2 1741000
0 473000
0 427000
0 383000
Commitments and contingencies (Note 6)
n/a
0 0
0 0
0 0
0 0
Redeemable Convertible Preferred Stock
n/a
76 76156000
0 0
0 0
0 0
Preferred stock
n/a
0 0
0 0
0 0
0 0
Common stock
n/a
0 0
0 3000
0 3000
0 4000
Treasury stock, at cost
n/a
0 0
0 0
0 0
0 0
Additional paid-in capital
n/a
1 1471000
160 160390000
271 271364000
413 412989000
Accumulated deficit
n/a
-53 -52597000
-56 -56080000
-111 -111085000
-243 -243461000
Total stockholders' equity
n/a
-51 -51126000
104 104313000
160 160282000
170 169532000
Total liabilities and stockholders' equity
n/a
104 103511000
163 162988000
199 199203000
218 217903000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (30 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net loss
-21
-1
-3
-55
-132
Acquired in-process research and development
0
0
0
0
40
Depreciation and amortization
0
1
1
1
1
Stock-based compensation
0
1
3
7
10
Loss on disposal of property and equipment
0
0
0
0
0
Accounts receivable
-2
0
-32
32
2
Prepaid expenses and other current assets
0
-1
-1
0
-2
Accounts payable
1
0
2
4
-4
Accrued expenses
1
3
2
0
4
Deferred revenue
30
40
-23
-24
8
Restricted cash and other assets
0
0
0
1
0
Other long-term liabilities
0
1
-1
0
0
Net cash used in operating activities
10
44
-54
-35
-73
Acquisition of in-process research and development
0
0
0
0
-40
Purchases of property and equipment
-1
-1
-1
-2
0
Proceeds from property insurance claim
0
0
0
0
0
Net cash used in investing activities
-1
-1
-1
-2
-40
Proceeds from sale of redeemable convertible preferred stock
19
22
0
0
0
Proceeds from public offering, net of commissions
0
0
82
101
131
Payment of common stock offering costs
0
0
-3
-1
0
Proceeds from reimbursement of common stock offering costs
0
0
0
0
0
Payment under capital lease obligation
0
0
0
0
0
Proceeds from stock options exercised
0
0
0
3
1
Excess tax benefit from stock option plan
0
0
0
0
0
Issuance of shares under employee stock purchase plan
0
0
0
0
0
Payment of redeemable convertible preferred stock issuance costs
0
0
0
0
0
Net cash provided by financing activities
19
22
80
104
131
Net increase in cash and cash equivalents
28
65
26
67
18
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 9, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,